Hypoxia Inducible Factor Activates the Transforming Growth Factor-α/Epidermal Growth Factor Receptor Growth Stimulatory Pathway in VHL-/- Renal Cell Carcinoma Cells

The Hallmarks of Cancer

2000 • 27,569 citations

Mutation and Cancer: Statistical Study of Retinoblastoma

1971 • 7,335 citations

Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis

1996 • 6,878 citations

Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O ₂ -Regulated Prolyl Hydroxylation

2001 • 5,255 citations

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

1999 • 4,973 citations

HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O ₂ Sensing

2001 • 4,537 citations

C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation

2001 • 3,215 citations

A Conserved Family of Prolyl-4-Hydroxylases That Modify HIF

2001 • 2,481 citations

G ₁ Events and Regulation of Cell Proliferation

1989 • 2,203 citations

Regulation of Mammalian O₂Homeostasis by Hypoxia-Inducible Factor 1

1999 • 1,882 citations

Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel–Lindau protein

2000 • 1,527 citations

Autocrine growth factors and cancer

1985 • 1,462 citations

Autocrine Secretion and Malignant Transformation of Cells

1980 • 1,370 citations

Hypoxia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor Protein

2000 • 1,018 citations

Independent function of two destruction domains in hypoxia-inducible factor-α chains activated by prolyl hydroxylation

2001 • 994 citations

Mechanism of regulation of the hypoxia-inducible factor-1alpha by the von Hippel-Lindau tumor suppressor protein

2000 • 889 citations

Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.

1996 • 886 citations

Molecular basis of the VHL hereditary cancer syndrome

2002 • 826 citations

A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase

1994 • 800 citations

Rbx1, a Component of the VHL Tumor Suppressor Complex and SCF Ubiquitin Ligase

1999 • 771 citations

EGF receptor ligands

2003 • 751 citations

HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation

2001 • 748 citations

Tumour suppression by the human von Hippel-Lindau gene product

1995 • 705 citations

Binding of the von Hippel-Lindau Tumor Suppressor Protein to Elongin B and C

1995 • 672 citations

Transformation of rat cells by DNA of human adenovirus 5

1973 • 664 citations

Activation of HIF1α ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex

2000 • 635 citations

von Hippel-Lindau Disease

1997 • 506 citations

Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan

1996 • 490 citations

HIF activation identifies early lesions in VHL kidneys

2002 • 469 citations

How Cancer Arises

1996 • 419 citations

The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity

1999 • 377 citations

von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF

2001 • 374 citations

Up-regulation of hypoxia-inducible factors HIF-1α and HIF-2α under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function

2000 • 368 citations

Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease

2001 • 364 citations

Expression in rat fibroblasts of a human transforming growth factor-α cDNA results in transformation

1986 • 346 citations

Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein.

1996 • 315 citations

Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.

2001 • 315 citations

Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation.

1994 • 272 citations

Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer

1995 • 259 citations

pVHL ₁₉ is a biologically active product of the von Hippel–Lindau gene arising from internal translation initiation

1998 • 248 citations

Human transforming growth factors induce tyrosine phosphorylation of EGF receptors

1981 • 244 citations

The von Hippel–Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal

1998 • 244 citations

Production of transforming growth factor alpha in human pancreatic cancer cells: evidence for a superagonist autocrine cycle.

1987 • 230 citations

PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner.

1997 • 205 citations

The von Hippel-Lindau Tumor Suppressor Gene

2020 • 201 citations

Identification of the von Hippel-Lindau (VHL) Gene

1995 • 198 citations

Role of transforming growth factor-alpha in von Hippel--Lindau (VHL)(-/-) clear cell renal carcinoma cell proliferation: a possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis.

2001 • 184 citations

Oxygen-Dependent Ubiquitination and Degradation of Hypoxia-Inducible Factor Requires Nuclear-Cytoplasmic Trafficking of the von Hippel-Lindau Tumor Suppressor Protein

2002 • 182 citations

TACE/ADAM17 Processing of EGFR Ligands Indicates a Role as a Physiological Convertase

2003 • 178 citations

Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.

1995 • 171 citations

Transforming growth factor alpha is a target for the von Hippel-Lindau tumor suppressor.

1998 • 170 citations

Transforming growth factor alpha: expression, regulation, and biological activities.

1995 • 166 citations

Expression of transforming growth factor alpha and epidermal growth factor receptor messenger RNA in neoplastic and nonneoplastic human kidney tissue.

1989 • 160 citations

Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations.

1995 • 153 citations

Expression of transforming growth factor alpha in normal human adult kidney and enhanced expression of transforming growth factors alpha and beta 1 in renal cell carcinoma.

1989 • 143 citations

Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice.

1998 • 140 citations

The pVHL-associated SCF ubiquitin ligase complex: Molecular genetic analysis of elongin B and C, Rbx1 and HIF-1α in renal cell carcinoma

2001 • 139 citations

Growth regulation of human renal carcinoma cells: role of transforming growth factor alpha.

1992 • 108 citations

Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice.

2003 • 103 citations

Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma.

1995 • 103 citations

Transformation of normal rat kidney (NRK) cells by an infectious retrovirus carrying a synthetic rat type alpha transforming growth factor gene.

1987 • 100 citations

In vitro formation and expansion of cysts derived from human renal cortex epithelial cells

1992 • 94 citations

Von Hippel‐Lindau Syndrome

1995 • 94 citations

Production and characterization of human 293 cell lines expressing the site-specific recombinase Cre

1996 • 89 citations

Modulation of pro-epidermal growth factor, pro-transforming growth factor alpha and epidermal growth factor receptor gene expression in human renal carcinomas.

1990 • 89 citations

Germline mutations in thevhl gene in patients presenting with phaeochromocytomas

1998 • 88 citations

Effects of transforming growth factor-beta, transforming growth factor-alpha, and other growth factors on renal proximal tubule cells.

1991 • 88 citations

Renal cysts in transgenic mice expressing transforming growth factor-alpha.

1994 • 84 citations

Cooperative Inhibition of Renal Cancer Growth by Anti-Epidermal Growth Factor Receptor Antibody and Protein Kinase A Antisense Oligonucleotide

1998 • 76 citations

Functions of the von Hippel–Lindau tumour suppressor protein

1998 • 74 citations

Genotype-phenotype correlation in von Hippel-Lindau disease: identification of a mutation associated with VHL type 2A.

1996 • 67 citations

The expression of epidermal growth factor receptor and transforming growth factor alpha in renal cell carcinoma.

1994 • 66 citations

Isolated familial pheochromocytoma as a variant of von Hippel-Lindau disease.

1996 • 61 citations

Generation of a Dominant-negative Mutant of Endothelial PAS Domain Protein 1 by Deletion of a Potent C-terminal Transactivation Domain

1999 • 60 citations

Role of Exon 2-encoded β-Domain of the von Hippel-Lindau Tumor Suppressor Protein

2001 • 56 citations

Transforming growth factor alpha: expression, regulation and biological action of its integral membrane precursor.

1990 • 47 citations

Coexpression of transforming growth factor-alpha and épidermal growth factor receptor in capillary hemangioblastomas of the central nervous system.

1995 • 46 citations

Tranilast inhibits protein kinase C‐dependent signalling pathway linked to angiogenic activities and gene expression of retinal microcapillary endothelial cells

1999 • 35 citations

Altered expression of transforming growth factor-α: An early event in renal cell carcinoma development

1997 • 31 citations